The company Biogen International Business Company located in Ireland will start up with the collaboration of companies and scientists from around the world a project to extend human life, thanks to blockchain technology it is now possible to participate.
Closed 2 weeks ago
| Pre-Sale | 03/01/2019 midnight - 03/31/2019 midnight |
|---|---|
| Token Sale | 04/01/2019 midnight - 09/30/2019 midnight |
| Country | Ireland |
| Type | ICO |
Token info
| Type | ICO |
|---|---|
| Token | HTER |
| Platform | Ethereum |
| Token Price | 0.0006 ETH (0.109626 USD) |
| Token for sale | 2,000,000,000 HTER (40%) |
| Token supply | 5,000,000,000 HTER |
Investment info
| Soft cap | 3,000,000 USD |
|---|---|
| Hard cap | 400,000,000 USD |
| Accepting | ETH |
| Restricted countries | China, United States of America |
| Know Your Customer | No |
| Whitelist | No |
| Bonus |
Phase 1 (PRIVATE) you will treat the discounted price with the investors Phase 2 (Pre-Ico) discount from 33,33% from 1 to 31 March 2019 the price of the token Hter will be 0.0004 Eth. |
-
1
INVESTOR SALE
OPEN INVESTOR SALE 12/01/2018
-
2
PRE ICO
OPEN PRE ICO 01/03/2019
-
3
ICO
OPEN ICO 01/04/2019
-
4
DISTRIBUTION TOKEN
DISTRIBUTION TOKEN 20/10/2019
-
5
LIST TOKEN ON EXCHANGE
LIST TOKEN ON EXCHANGE 01/12/2019
-
6
START UP OF THE PROJECT
START UP OF THE PROJECT SIGNING OF AGREEMENTS OR HIRING SCIENTISTS
Closed 2 weeks ago
| Pre-Sale | 03/01/2019 midnight - 03/31/2019 midnight |
|---|---|
| Token Sale | 04/01/2019 midnight - 09/30/2019 midnight |
| Country | Ireland |
| Type | ICO |
Financial information
| Platform | Ethereum |
|---|---|
| Whitelist/KYC | Not needed |
| Token price | 0.0006 ETH |
| Bonus | Available |
Interest
| Alexa rank | 3,306,921 th |
|---|---|
| Twitter followers | 259 |
| Promotional video views | 2,977 |
TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.